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Abstract
 More than 2 million people per year are treated for surgicalBackground:
wounds in the UK.  Over a quarter of these wounds are estimated to heal by
secondary intention (from the “bottom up”) resulting in further complications
and requiring increased healthcare resources. Identification of
microbiological or host biomarkers that can predict healing outcomes may
help to optimize the management of surgical wounds healing by secondary
intention. However, the microbial and host factor heterogeneity amongst
this diverse population is completely unexplored.
 We demonstrate feasibility of determining presence and levels ofMethods:
wound microbes and systemic host factors in an inception cohort of 54
people presenting with surgical wounds healing by secondary intention,
who were subsequently followed-up for a period of 12-21 months. We
present descriptive statistics for plasma levels of inflammatory, angiogenic
cytokines and microRNAs, and we identify a range of wound colonizing
microbes. We tentatively explore association with healing aiming to
generate hypotheses for future research.
 We report a potential correlation between poor healing outcomesResults:
and elevated interleukin (IL)-6 plasma levels at presentation (ρ=0.13) which
requires confirmation.  
This study demonstrates the degree of biologicalConclusions: 
heterogeneity amongst people with surgical wounds healing by secondary
intention and proves the feasibility of embedding a biomarker discovery
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 intention and proves the feasibility of embedding a biomarker discovery
study in a cohort study in surgical wounds. Our results are essential for
designing large biomarker discovery studies to further investigate the
potential validity of circulating IL-6 or other factors as novel predictive
biomarkers of healing for surgical wounds healing by secondary intention.
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Introduction
Over ten million surgical operations are performed in the 
United Kingdom (UK) each year1. Surgical wounds are 
usually closed by primary intention, where wound edges are 
held together whilst healing occurs using sutures (stitches), 
staples, adhesive or clips. However, some wounds heal by 
secondary intention, where the wound is left to open to heal 
from the ‘bottom up’. This type of healing may occur when 
healing by primary intention fails (for example, due to infec-
tion) or may be planned (for example, following excision of a 
pilonidal sinus, or incision and drainage of a perianal 
abscess). Wounds healing by secondary intention may be 
subsequently closed surgically.
Two published audit studies from the North of England esti-
mated that surgical wounds healing by secondary intention 
(SWHSI) constitute approximately 28% of all prevalent acute 
(mainly surgical/traumatic) wounds that were receiving wound 
care provision2,3. More recent research, also in the North of 
England, estimated that SWHSI have a point prevalence 
of 4.1 per 10,000 population (95% confidence interval 
(CI) = 3.5 to 4.7)4.
SWHSI are managed in both acute and community settings 
where they can be challenging to manage as they present spe-
cific management problems such as high levels of exudate and a 
risk of cross-infection and trauma. In our cohort study, we esti-
mated that SWHSI have a median time to healing of 86 days 
(95% CI: 75 to 103)5 and therefore whilst accurate cost data 
are not available, SWHSI are clearly costly for the National 
Health Service (NHS). Importantly, we have also shown they 
have a huge and adverse impact on people’s quality of life6. 
SWHSI are clearly a topic deserving of more research and 
effective treatments.
The identification of prognostic factors that predict heal-
ing, complications and/or treatment response in people with 
SWHSI would enable a paradigm shift towards improving 
wound management and reducing healthcare costs. However, 
there is a notable lack of research on the immunological and 
microbiological phenotype of SWHSI. Although some research 
on the predictive biomarkers of healing has been under-
taken in wounds such as venous and diabetic ulcers7,8, there 
are no studies on biological biomarkers of SWHSI healing. 
A potential challenge in identifying predictive biomark-
ers in SWHSI is the heterogeneity of the patients (including 
their underlying pathophysiology) and the wounds.
Here, we present an initial characterisation of the immuno-
logical and microbial wound landscape in a small cohort of 
patients with SWHSI. We demonstrate that a biomarker discov-
ery study can be embedded in research in this field, leading the 
way for future research. We report a wide range of microbial 
species present in SWHSI and determine circulating lev-
els of selected cytokines and nucleic acids (microRNAs) at 
presentation. We chose to determine levels of interleukin 
(IL)-6 and angiopoietin-2 (ANG-2), two cytokines that are 
have been suggested to be associated with wound inflammation, 
angiogenesis, and healing9–12. Similarly, we determined plasma 
levels of miR-146a and miR-126, which are also implicated 
in skin inflammation, angiogenesis, and wound healing13,14. 
We provide exploratory information on heterogeneity in wound 
and systemic parameters across individuals with SWHSI, 
which can be used for designing larger biomarker discov-
ery studies. Furthermore, we cautiously investigate possible 
associations between baseline microbiological and immunologi-
cal factors and wound healing, and identify blood plasma IL-6 
levels as a potential candidate biomarker of healing of SWHSI.
Methods
Study participants
This feasibility study was nested in a larger inception cohort 
study5 that recruited participants with an incident SWHSI 
(present for 3 weeks or less at recruitment into the cohort). 
These wounds were defined as ‘open surgical wounds heal-
ing from the bottom up via the formation of granulation tissue’ 
and where the open wound required treatment. Our definition of 
SWHSI inclusion and exclusion criteria are detailed in Table 1.
No formal sample size calculation was conducted as this 
was a feasibility study, the achieved sample size of 54 par-
ticipants was deemed sufficient to provide initial descriptive 
statistics and identify potential associations between tested 
biological and epidemiological factors for healing. 
We collected baseline demographic and wound characteris-
tics data including: participant age, gender, co-morbidities and 
smoking status. Participants were then followed for between 
12 months and 21 months to determine time to wound healing 
and data were collected on key events such as re-operations and 
infections. All participants provided written informed consent 
to participate in the study. The study was conducted accord-
ing to the principles of the Declaration of Helsinki 1975 and 
ethics approval was granted by National Research Ethics 
Service Committee Yorkshire and the Humber South Yorkshire 
on 06.12.2012 (Reference: 12/YH/0537). 
Biological sample collection, transport and storage
At entry into the cohort study some participants gave con-
sent to provide up to two biological samples (a wound swab 
and a blood sample). Research nurses obtained wound swabs 
at baseline using a standardised technique: the wound was not 
cleansed before taking the swab to ensure the maximum number 
of bacteria were present and the technique aimed to swab 
purulent discharge if it was present. In the absence of puru-
lent discharge, the swab was taken from an area of the wound 
containing viable tissue where possible (e.g. granulating tis-
sue). To collect the specimen the wound swab was rotated 
over a 1cm2 area of the wound, applying light pressure with the 
aim of saturating the swab. If the wound was dry, the swab 
was moistened with sterile water or sterile saline to aid in 
the collection of the specimen. Research nurses were asked 
to avoid taking the sample from areas of the wound covered 
with slough or necrotic tissue. All swabs were then transported 
in bacteriological transport medium, at room temperature, 
within three hours of collection by courier.
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Blood samples were collected from consenting patients at base-
line using standard venepuncture techniques. Samples were 
transported within three hours to the University of York and 
logged in for plasma isolation following standard operating pro-
cedures. In brief, samples were centrifuged and the cellular 
component of the blood sample discarded. The remaining 
plasma sample was aliquoted (at least 7 aliquots of 0.5ml per 
participant) and stored at below -70 degrees centigrade. All 
practice followed good laboratory practice guidelines.
Microbiological analysis
Basic microbiological analyses were conducted using local 
laboratory standard operating procedures based on the UK 
Standards for Microbiological Investigations produced by 
Public Health England15. Wound swabs were inoculated onto 
the following agar plates sequentially in order to obtain 
single bacterial colonies: Blood agar (mainly for Gram- 
positive bacteria); cystine-lactose-electrolyte-deficient (CLED) 
agar (mainly for Gram-negative bacteria) and anaerobic blood 
agar (for anaerobic bacteria). Blood agar plates were incubated 
in CO2 at 37°C for 24 hours then read and re-incubated for a 
further 24 hours; CLED plates in an aerobic atmosphere at 
37°C for 24 hours; and anaerobic agar plates in an anaerobic 
atmosphere at 37°C for 48 hours then read and re-incubated 
as necessary for a further 5 days with a 5μg metronidazole 
disc placed at the time of first streaking out from the main 
inoculum.
Subsequent microbial growth was differentiated and identified 
according to the UK Standards for Microbiological Investigations 
produced by Public Health England15 and qualitatively cat-
egorized into the following groups: 1) no bacterial growth; 
2) the presence of skin commensals only (coagulase negative 
Staphylococcus species, Micrococcus species, and diphtheroid 
bacilli); and 3) growth of one or more of the following poten-
tially pathogenic bacteria (with or without the presence of skin 
commensals): Staphylococcus aureus (methicillin sensitive 
and resistant), Lancefield Group A, B, C and G Streptococci, 
anaerobes, coliforms and Pseudomonas spp.
Measurement of plasma cytokine levels and circulating 
microRNA levels. IL-6 and ANG-2 levels were measured with 
commercially available enzyme immunoassays (R&D Sys-
tems: Human IL-6 Quantikine ELISA Kit, product number: 
D6050; Human Angiopoietin-2 Quantikine ELISA Kit, product 
number: DANG20), following manufacturer’s instructions, 
using the plasma samples following blood separation.
Two microRNAs were measured, miR-146a and miR-126. 
Ribonucleic acid (RNA) was extracted from 50μl of plasma. 
MiRNA reverse transcription was performed (TaqMan 
MicroRNA Reverse Transcription Kit; Applied Biosystems), 
as per manufacturer’s instructions, and relative levels were 
determined by quantitative polymerase chain reaction (PCR) 
using Taqman microRNA primers (Applied Biosystems). TaqMan 
Assays (including primers) for miR-146a and miR-126 were 
purchased from ThermoFischer (catalogue number 4440886 for 
both). Master mixes were prepared in Taqman Universal PCR 
Master Mix (catalogue number 4304437). PCR was car-
ried out using a StepOnePlus Real Time PCR System with the 
following cycling conditions: 95°C for 10mins, 40 cycles of 
[95°C for 15 seconds, 60°C for 30 seconds, 72°C for 
Table 1. Definition of surgical wounds healing by secondary intention (SWHSI) used in our study.
Included
1. Wounds that had been left open following surgery (i.e. due to contamination, swelling or infection or because there is an empty 
space below the wound)
2. Wounds that may have been closed by sutures, clips etc. at surgery but then partially or completely opened, or dehisced
3. Open wounds resulting from surgical or sharp debridement which may have been non-surgical in origin e.g. surgical 
debridement of a grade III/IV pressure ulcer, sharp debridement of a foot ulcer
Excluded
1. Wounds with planned delayed primary closure (i.e. surgical wounds left open for 5 to 7 days after surgery with planned closure 
thereafter). However, if these wounds then became SWHSI (as defined above) they became eligible for inclusion
2. Wounds left open with no planned healing, e.g. stoma, tracheotomies, gastrostomies
3. Surgery without an incision on the skin surface, e.g. tonsillectomy, dilation and curettage (i.e. “internal” wounds)
4. Split-skin donor graft sites
5. Nail avulsions
6. Cavities resulting from dental extractions
7. Operations involving the eye (i.e. cataract surgery and removal of the eye)
8. Wounds that are a consequence of minor dermatological or plastic surgery (e.g. removal of warts, skin tags) or diagnostic 
procedures (e.g. punch biopsy)
9. Recurrence of a SWHSI that had previously healed
10. Participants previously recruited to this study
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40 seconds], 95°C for 60 seconds. The DeltadeltaCt method 
was used for quantification. cDNA (corresponding to 1ng 
total RNA) from primary dermal microvascular endothelial 
cells was used as reference.
Data analysis
Data analysis was undertaken using Stata v13 or later16, 
proportions of missing data were explored for all variables. 
Population characteristics are presented descriptively. Wound 
healing is summarised using a Kaplan-Meier curve and 
median time to healing is presented with 95% CI. Baseline 
immunological parameter concentrations are presented descrip-
tively both overall and stratified by healing status at the end 
of the main cohort follow-up period. Where observed values 
were below the assay of the test, a value of half the assay was 
imputed for analysis purposes. Due to the skewed nature of the 
concentration variables, t-tests were performed on logarith-
mically transformed data to assess the difference in means 
between participants who healed and those who did not. 
Pearson’s correlation coefficients examined association between 
time to healing and parameter concentrations.
Microbiological species are illustrated using frequencies and 
percentages for the sample overall and by healing status. Fish-
er’s exact tests were used to examine possible associations 
between healing status (healed/not) and the presence of the 
three most common microbes states in the wound at baseline: 
gastrointestinal bacteria (defined as the presence of one or 
more of coliform (Enterobacteriaceae, Pseudomonas or Ente-
rococcus species), coliforms and skin commensals. Log-rank 
tests compared time to healing by presence of microbiologi-
cal parameters. T-tests on log-transformed data compared mean 
concentrations of immunological parameters by presence of 
selected microbiological parameters. Microbiological param-
eters to be examined were selected a priori to minimise the risk 
of Type I error.
Given the limited sample size, detailed adjusted analysis was 
not possible, however we identified diabetes as a potential con-
founding factor of interest due to the well-established link 
between diabetes and impaired healing17,18, and studies indicat-
ing deregulated levels of IL-619,20, ANG-221,22, miR-146a23,24, and 
miR-12625,26 in individuals with diabetes. Thus we also present 
analysis of immunological factors by diabetes status. For 
microbial analysis we only present unadjusted analyses.
Results
Description of study population
In total, 54 (13.7%) people within the overall cohort of 393 eli-
gible individuals consented to this sub-study of whom 51 
(94.4%) provided a blood sample, and 44 (81.5%) a wound 
swab, with 42 (78%) provided both. Table 2 shows baseline 
characteristics of these consenting individuals; mean age was 
approximately 52 years (SD 19.1) and 61.1% of participants 
were male. Non-smokers constituted 64.8% of the sample 
and 27.8% were current smokers (or had quit in the last 
year). Cardiovascular disease (33.3%) and diabetes (25.9%) 
were common co-morbidities. Baseline wound infection was 
Table 2. Summary statistics for participant baseline characteristics. SWHSI: 
surgical wounds healing by secondary intention.
N=54 
Gender Male, n (%) 33 (61.1)
Age in years Mean (SD) 51.7 (19.1)
Median (range) 52.3 (19.5, 83.2)
Smoking status None in the last 10 years, n (%) 35 (64.8)
None current but in last 10 years, n (%) 4 (7.4)
Current or quit in last year, n (%) 15 (27.8)
Co-morbidity Cardiovascular disease, n (%) 18 (33.3)
Diabetes, n (%) 14 (25.9)
Peripheral vascular disease, n (%) 9 (16.7)
Cancer, n (%) 7 (13.0)
Arthritis, n (%) 6 (11.1)
Orthopaedics, n (%) 6 (11.1)
Airways, n (%) 5 (9.3)
Stroke, n (%) 5 (9.3)
Other, n (%) 3 (5.6)
Number of SWHSI Mean (SD) 1.1 (0.32)
Median (range) 1 (1, 2)
Wound infection, Yes*, n (%) 12 (22.2)
Antibiotic use¶ Yes§, n (%) 22 (40.1)
* Baseline wound infection missing for n=2 (3.7%); ¶ SWHSI related antibiotic use 
§ Specifically: oral (n=10, 18.5%); intravenous (n=12, 22.2%); and no topical antibiotic use.
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present for 12 participants (22.2%); intravenous antibiotics 
for SWHSI were reported for 12 participants (22.2%) and oral 
antibiotics for 10 participants (18.5%).
Baseline wound characteristics are shown in Table 3. Over 60% 
of SWHSI were planned; one-quarter because it was not pos-
sible to approximate the wound edges; one-third due to infec-
tion; and a further 37% of wounds partially dehisced after 
surgery. Mean baseline SWHSI area was 36.0cm2 (SD 68.8). 
Colorectal and vascular surgery accounted for over 60% of 
surgeries (38.9% and 22.2% respectively); with nearly 60% 
of wounds being abdominal or leg wounds (33.3% and 24.1% 
respectively).
Wound healing
Healing occurred in 43 participants during follow-up (79.6%) 
and 11 individuals (20.4%) had a recurrence within the study 
period. The median time to healing in this population was 
83 days (95% CI: 59 to 121 days; Figure 1) as compared 
with 86 days (95% CI: 75 to 103) in the larger cohort5.
Analysis of plasma IL-6, ANG-2, miR-146a, and miR-126 
levels in SWHSI. Table 4 shows summary statistics for 
baseline IL-6 and ANG-2 concentration. Mean ANG-2 concentra-
tion in non-healers was nearly twice that of healers (5876pg/ml 
compared with 3412pg/ml) although this difference was not 
statistically significant at the 5% level (p=0.06). The mean base-
line IL-6 concentration was significantly higher for those who 
did not heal than that for those who healed (p<0.01) with mean 
values of 86.9pg/ml (SD 104.4pg/ml) and 29.8pg/ml (SD 
136.9pg/ml) respectively. In general, people with higher levels 
of ANG-2 took longer to heal, although this positive correlation 
was weak (ρ=0.35). There was also a very weak positive 
correlation between time to healing and IL-6 concentration 
suggesting that those with higher levels of IL-6 may take longer 
to heal (ρ=0.13). 
The mean of miR-126 was 0.5AU/ml (SD 0.4AU/ml) and for 
miR-146a was 9.3AU/ml (SD 6.9AU/ml). There was no evi-
dence of a difference between healed and unhealed participants 
in terms of mean miR126 (p=0.74) or miR146a (p=0.82). 
There was a negligible association between time to healing 
and miR-126 (ρ=0.03) and miR-146a (ρ=-0.04).
Healing and diabetes. Time to healing was explored in a 
log-rank test by diabetic status (14 participants with diabe-
tes and 40 without). Results showed evidence of a statistically 
significant difference in time to healing between the two 
groups (p<0.01) with median time to healing for those with 
diabetes being longer than for those without at 94 days (95% 
CI: 59, not estimable) compared to 78 days (95% CI: 53, 121).
Table 5 shows summary statistics for baseline immunological 
parameter concentrations by diabetic status. Mean concentration 
levels of ANG-2, IL-6, miR-126 and miR-146a were higher 
in those with diabetes than for those without. Within only those 
Table 3. Summary statistics for baseline wound characteristics. SWHSI: surgical 
wounds healing by secondary intention.
N=54 
SWHSI area (cm2) Mean (SD) 36.0 (68.8)
Median (range) 7.6 (0.1, 384)
Reason for SWHSI Dehisced, n (%) 1 (1.9)
Partially dehisced, n (%) 20 (37.0)
Planned due to wound edges, n (%) 14 (25.9)
Planned due to infection, n (%) 18 (33.3)
Planned for other reason, n (%) 1 (1.9)
Surgery leading to SWHSI Colorectal, n (%) 21 (38.9)
Vascular, n (%) 12 (22.2)
Other, n (%) 11 (20.4)
Plastics, n (%) 5 (9.3)
Obs/gynae, n (%) 3 (5.6)
Orthopaedic, n (%) 2 (3.7)
Location of SWHSI* Abdomen, n (%) 18 (33.3)
Foot, n (%) 7 (13.0)
Leg, n (%) 13 (24.1)
Peri-anal area, n (%) 7 (13.0)
Other, n (%) 5 (9.3)
*4 participants missing information on location of SWHSI (7.4%).
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Figure 1. Kaplan-Meier curve of time to wound healing.
Table 4. Summary statistics for baseline immunological parameter concentrations, 
overall and by healing status.
Overall 
N=51* Healed N=42 Not healed N=9 
Difference‡ 
(95% CI) p-value§ 
Angiopoietin-2 (pg/ml) 
Mean (SD) 3847 (2998) 3412 (1501) 5876 (6247) 1.4 (1.0, 2.0) 0.06
Median 3319 3313 4781 - -
Min, max 1473, 22195 1473, 7905 2097, 22195 - -
Interleukin-6† (pg/ml) 
Mean (SD) 39.8 (132.6) 29.8 (136.9) 86.9 (104.4) 5.2 (1.9, 14.5) <0.01 
Median 7.3 5.6 64.5 - -
Min, max 1.6, 893.1 1.6, 893.1 1.6, 300.4 - -
miR-126 (AU/ml) 
Mean (SD) 0.5 (0.4) 0.5 (0.4) 0.6 (0.4) 1.1 (0.7, 1.8) 0.74
Median 0.4 0.4 0.4 - -
Min, max 0.1, 2.7 0.1, 2.7 0.2, 1.3 - -
miR-146a (AU/ml) 
Mean (SD) 9.3 (6.9) 9.5 (7.2) 8.5 (5.1) 0.93 (0.5, 1.7) 0.82
Median 7.9 7.6 9.6 - -
Min, max 1.1, 26.8 1.1, 26.8 1.3, 15.8 - -
*3 individuals without a blood sample; ‡ difference in geometric means, presented in terms of 
geometric means due to log-transformation of data prior to testing.; § log rank test p-value; † 14 
samples (13 healed; 1 unhealed) where concentration was below the assay detection limit of  
3.1pg/ml with values set at 1.55 pg/ml (half the assay).
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without diabetes (n=37) the mean IL-6 concentration (back 
transformed) at baseline was 6.4 pg/ml (SD 12.1) in those that 
went onto heal compared with 90 pg/ml (SD 243.1) in those 
who did not (p<0.01).
Analyses of microbial species present in SWHSI
Table 6 shows summary statistics for baseline microbiologi-
cal parameters. Overall, gastrointestinal bacteria (as defined 
above) were the most frequently observed (in 70.5%) fol-
lowed by coliforms and skin commensals (both in 50.0%). 
Gastrointestinal bacteria were slightly less common in wounds 
that ultimately healed compared with those that did not (66.7% 
and 87.5% respectively). Coliforms were also more preva-
lent in wounds that did not heal (62.5%) compared with those 
that healed (47.2%). There were no clear differences between 
healers and non-healers in the prevalence of skin commensals 
or Enterococcus species. In general, proportions of other 
bacteria were higher for those who did not proceed to heal-
ing during follow up compared with those who healed. 
Fisher’s exact tests found no evidence of an association between 
healing status and gastrointestinal bacteria (p=0.40), coliform 
(p=0.70) or skin commensals (p=1.00).
There was no evidence of a statistically significant differ-
ence in time to healing (based on a log rank test, Table 7) 
dependent on presence of gastrointestinal bacteria (p=0.28), 
Table 5. Summary statistics for baseline 
immunological parameter concentrations, by 
diabetic status.
Diabetic N=14 Non-diabetic N=37 
Angiopoietin-2 (pg/ml)
Mean (SD) 5760 (4908) 3123 (1351)
Median 4789 3111
Min, max 2063, 22195 1473, 7095
Interlukein-6† (pg/ml)
Mean (SD) 49.1 (91.2) 36.3 (146.2)
Median 11.6 4.4
Min, max 1.6, 300.4 1.6, 893.1
miR-126 (AU/ml)
Mean (SD) 0.6 (0.6) 0.5 (0.3)
Median 0.4 0.5
Min, max 0.2, 2.7 0.1, 1.3
miR-146a (AU/ml)
Mean (SD) 10.1 (6.8) 9.1 (7.0)
Median 9.3 7.3
Min, max 2.15, 25.5 1.1, 26.8
† 14 samples (13 healed; 1 unhealed) where concentration 
was below the assay detection limit of 3.1pg/ml with values 
set at 1.55 pg/ml (half the assay).
Table 6. Baseline microbe presence, overall and by healing 
status.
Overall Not 
healed
Healed
N=44 N=8 N=36
Gastrointestinal bacteria*, n (%) 31 (70.5) 7 (87.5) 24 (66.7)
Coliform (one or more), n (%) 22 (50.0) 5 (62.5) 17 (47.2)
Skin commensals, n (%) 22 (50.0) 4 (50.0) 18 (50.0)
Enterococci, n (%) 11 (25.0) 2 (25.0) 9 (25.0)
More than one coliform, n (%) 7 (15.9) 1 (12.5) 6 (16.7)
Staphylococcus aureus, n (%) 8 (18.2) 2 (25.0) 6 (16.7)
Anaerobe, n (%) 6 (13.6) 0 (0.0) 6 (16.7)
Pseudomonas aeruginosa, n (%) 3 (6.8) 2 (25.0) 1 (2.8)
Group B streptococci, n (%) 3 (6.8) 1 (12.5) 2 (5.6)
No growth, n (%) 3 (6.8) 1 (12.5) 2 (5.6)
α haemolytic streptococci, n (%) 1 (2.3) 0 (0.0) 1 (3.8)
Candida, n (%) 1 (2.3) 0 (0.0) 1 (2.8)
Enterobacter cloacae, n (%) 1 (2.3) 0 (0.0) 1 (2.8)
Streptococcus milleri, n (%) 1 (2.3) 1 (12.5) 0 (0.0)
* Defined as the presence of one or more of “coliform”, Pseudomonas, 
Enterococcus or Enterobacter species.
Table 7. Time to wound healing, by microbe presence.
n (%) Median TTH* (95% CI) Log rank
Present Not present Present Not present p-value
Gastrointestinal bacteria 31 (70.5) 13 (29.5) 83 (53, 142) 70 (41, 112) 0.28
Coliform (one or more) 22 (50.0) 22 (50.0) 85 (48, 193) 76 (53, 122) 0.42
Skin commensals 22 (50.0) 22 (50.0) 70 (49, 94) 85 (53, 142) 0.77
Enterococci 11 (25.0) 33 (75.0) 76 (28, 233) 83 (53, 121) 0.98
More than one coliform 7 (15.9) 37 (84.1) 85 (16, 142) 78 (56, 121) 0.87
Staphylococcus aureus 7 (15.9) 37 (84.1) 78 (20, .] 78 (53, 121) 0.89
Anaerobe 6 (13.6) 38 (86.4) 70 (17, .] 78 (53, 142) 0.14
*Median TTH = median time to healing in days; . = unable to estimate
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coliforms (p=0.42), skin commensals (p=0.77), Enterococ-
cus species (p=0.98), more than one coliform (p=0.87), 
Staphylococcus aureus (p=0.89) or anaerobes (p=0.14).
Discussion
There has been limited previous analysis of immunological 
and microbial factors that predict surgical wound outcomes. 
This lack of research is matched by a lack of epidemiologi-
cal research into SWHSI and consequently there is currently no 
published data (of which we are aware) that present even initial 
exploration of parameter heterogeneity and possible biomarkers 
for healing.
Key results 
We have provided important, initial descriptive data con-
cerning some putative prognostic factors for healing in open 
surgical wounds. Most previous research exploring prog-
nostic factors in wound healing has been cross-sectional27 
or in animals28; however, we are uniquely able to explore poten-
tial associations between related baseline levels factors and 
verified healing outcomes because our study was nested in a 
larger inception cohort. This study provides metrics and descrip-
tive statistics for this heterogeneous population of individu-
als with SWHSI and presents pilot data. Our study provides 
the first data set describing the extent of variability in the 
expression of circulating factors amongst individuals with 
SWHSI. This is vital information required for designing larger 
predictive biomarker discovery studies. It also indicates that 
it is feasible to nest smaller explorative biomarker studies 
within a larger cohort study within wound care. Notably, we 
found that at baseline individuals who did not heal during the 
follow up of the study displayed significantly higher plasma lev-
els of IL-6 and ANG-2 in this study population. Interestingly, 
this trend was maintained for IL-6 even when we limited the 
analysis to people with no diabetes.
Experimental animal model studies of wound healing have 
suggested that IL-6 is essential for wound healing9,10, but con-
versely high IL-6 levels in exudates from venous ulcers have 
been associated with poor healing outcomes12. This apparent 
discordance between human and animal studies is most likely 
due to differences between tractable experimental models and 
heterogeneous human cohorts, and also may be a result of 
distinct effects of IL-6 during the different stages of wound 
healing and repair.
Our results indicate a wealth of colonising or infecting micro-
bial organisms present in SWHSI, including skin commensals, 
potential pathogenic microbes (e.g. Staphylococcus aureus, 
Pseudomonas aeruginosa), and coliforms. That such a high 
proportion of wounds had gastrointestinal bacteria is unsur-
prising given that 60% of wounds were of the abdomen or 
lower limb. Further studies can build on our results to deter-
mine the SWHSI microbiome at higher resolution using larger 
cohorts and unbiased (non-culture) techniques29. Interestingly, 
we did not observe any potential correlations between microbial 
species and healing outcomes of SWHSI. Larger studies are 
required to address this question. The results presented here 
provide a starting point and are essential in designing such 
studies. Understanding such potential correlations between 
bacterial colonisation, biomarkers, rational use of antibiot-
ics, and healing outcomes is likely to have significant impact on 
wound care. 
Limitations 
This was a small study and therefore our comparisons of fac-
tors between people who healed and people who didn’t are 
likely to be underpowered to detect some differences as sta-
tistically significant. Furthermore, the small size of the 
cohort precluded extensive exploration of confounding 
factors between factor levels and wound healing, such as 
smoking status and infection status. However, diabetes was 
investigated as a potential confounding factor and simple 
stratified analyses were conducted. Caution should be taken 
when attempting to draw conclusions from such small cohorts 
and our findings require further validation in larger cohorts. 
Additionally, as the study concerns an inception cohort, the 
data are not designed to allow for causal links to be established, 
and whilst efforts have been made to reduce the risk of inflated 
Type I error, results would need to be verified in future 
research. Finally, we only collected data at baseline so we 
are unable to comment on the trajectories of factors over time.
Implications 
Overall, our study demonstrates the feasibility of biomar-
ker discovery studies for SWHSI, despite the clinical het-
erogeneity of these complex wounds. Our results pro-
vide a solid foundation for designing robust biomarker 
discovery studies for SWHSI. Such studies are necessary for 
patient stratification, improved wound management, and are likely 
to have significant impact on healthcare resources and use 
of antibiotics. Given that therapeutic anti-IL-6 agents are 
now used in other areas of medicine, the potential correla-
tion between enhanced baseline IL-6 levels and impaired 
healing is intriguing and requires further investigation in clinical 
and mechanistic studies.
We note that the relationships between possible biomark-
ers and healing is likely complex and could be mediated by 
other factors and/or cofounded by various cellular, wound and 
participant factors. Ultimately extensive further prognostic 
work in large cohorts of patients that adjust extensively for 
important factors are required. The design of such studies 
should be informed by careful exploration of existing data using 
systematic review approaches.
Data availability
Access to data will require a formal data request form to 
be completed, as informed consent was not obtained from 
participants for public data sharing. The data request form can 
be obtained by contacting York Trials Unit at: catherine.arundel@
york.ac.uk.
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In accordance with the associated participant consent com-
pleted in relation to this study, anonymised sample data can be 
shared for use in medical research, where this research has been 
granted research ethics approval.
Access to data will be permitted on completion of a signed and 
authorised data request form. The recipient will be responsible 
for maintaining and protecting the integrity of the data 
and using this only for the purposes for which the request 
was made. Data must be stored securely and not passed on or 
have access granted to anyone other than those listed in the 
completed request form.
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